Table of Content

1.Product Overview
1.1.Market Definition
1.2.Scope of the Market
1.2.1.Markets Covered
1.2.2.Years Considered for Study
1.2.3.Key Market Segmentations
2.Research Methodology
2.1.Objective of the Study
2.2.Baseline Methodology
2.3.Key Industry Partners
2.4.Major Association and Secondary Sources
2.5.Forecasting Methodology
2.6.Data Triangulation Validation
2.7.Assumptions and Limitations
3.Executive Summary
3.1.Overview of the Market
3.2.Overview of Key Market Segmentations
3.3.Overview of Key Market Players
3.4.Overview of Key Regions/Countries
3.5.Overview of Market Drivers, Challenges, Trends
4.Global T-cell Therapy Market Outlook
4.1.Market Size Forecast
4.1.1.By Value
4.2.Market Share Forecast
4.2.1.By Therapy Type (CAR T-cell Therapy, T Cell Receptor (TCR)-based, Tumor Infiltrating Lymphocytes (TIL)-based))
4.2.2.By Indication (Hematologic Malignancies,Solid Tumors, Others)
4.2.3.By Region
4.2.4.By Company (2023)
4.3.Market Map
4.3.1.By Therapy Type
4.3.2.By Indication
4.3.3.By Region
5.Asia Pacific T-cell Therapy Market Outlook
5.1.Market Size Forecast
5.1.1.By Value
5.2.Market Share Forecast
5.2.1.By Therapy Type
5.2.2.By Indication
5.2.3.By Country
5.3.Asia Pacific: Country Analysis
5.3.1.China T-cell Therapy Market Outlook
5.3.1.1.Market Size Forecast
5.3.1.1.1.By Value
5.3.1.2.Market Share Forecast
5.3.1.2.1.By Therapy Type
5.3.1.2.2.By Indication
5.3.2.India T-cell Therapy Market Outlook
5.3.2.1.Market Size Forecast
5.3.2.1.1.By Value
5.3.2.2.Market Share Forecast
5.3.2.2.1.By Therapy Type
5.3.2.2.2.By Indication
5.3.3.Australia T-cell Therapy Market Outlook
5.3.3.1.Market Size Forecast
5.3.3.1.1.By Value
5.3.3.2.Market Share Forecast
5.3.3.2.1.By Therapy Type
5.3.3.2.2.By Indication
5.3.4.Japan T-cell Therapy Market Outlook
5.3.4.1.Market Size Forecast
5.3.4.1.1.By Value
5.3.4.2.Market Share Forecast
5.3.4.2.1.By Therapy Type
5.3.4.2.2.By Indication
5.3.5.South Korea T-cell Therapy Market Outlook
5.3.5.1.Market Size Forecast
5.3.5.1.1.By Value
5.3.5.2.Market Share Forecast
5.3.5.2.1.By Therapy Type
5.3.5.2.2.By Indication
6.Europe T-cell Therapy Market Outlook
6.1.Market Size Forecast
6.1.1.By Value
6.2.Market Share Forecast
6.2.1.By Therapy Type
6.2.2.By Indication
6.2.3.By Country
6.3.Europe: Country Analysis
6.3.1.France T-cell Therapy Market Outlook
6.3.1.1.Market Size Forecast
6.3.1.1.1.By Value
6.3.1.2.Market Share Forecast
6.3.1.2.1.By Therapy Type
6.3.1.2.2.By Indication
6.3.2.Germany T-cell Therapy Market Outlook
6.3.2.1.Market Size Forecast
6.3.2.1.1.By Value
6.3.2.2.Market Share Forecast
6.3.2.2.1.By Therapy Type
6.3.2.2.2.By Indication
6.3.3.Spain T-cell Therapy Market Outlook
6.3.3.1.Market Size Forecast
6.3.3.1.1.By Value
6.3.3.2.Market Share Forecast
6.3.3.2.1.By Therapy Type
6.3.3.2.2.By Indication
6.3.4.Italy T-cell Therapy Market Outlook
6.3.4.1.Market Size Forecast
6.3.4.1.1.By Value
6.3.4.2.Market Share Forecast
6.3.4.2.1.By Therapy Type
6.3.4.2.2.By Indication
6.3.5.United Kingdom T-cell Therapy Market Outlook
6.3.5.1.Market Size Forecast
6.3.5.1.1.By Value
6.3.5.2.Market Share Forecast
6.3.5.2.1.By Therapy Type
6.3.5.2.2.By Indication
7.North America T-cell Therapy Market Outlook
7.1.Market Size Forecast
7.1.1.By Value
7.2.Market Share Forecast
7.2.1.By Therapy Type
7.2.2.By Indication
7.2.3.By Country
7.3.North America: Country Analysis
7.3.1.United States T-cell Therapy Market Outlook
7.3.1.1.Market Size Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share Forecast
7.3.1.2.1.By Therapy Type
7.3.1.2.2.By Indication
7.3.2.Mexico T-cell Therapy Market Outlook
7.3.2.1.Market Size Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share Forecast
7.3.2.2.1.By Therapy Type
7.3.2.2.2.By Indication
7.3.3.Canada T-cell Therapy Market Outlook
7.3.3.1.Market Size Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share Forecast
7.3.3.2.1.By Therapy Type
7.3.3.2.2.By Indication
8.South America T-cell Therapy Market Outlook
8.1.Market Size Forecast
8.1.1.By Value
8.2.Market Share Forecast
8.2.1.By Therapy Type
8.2.2.By Indication
8.2.3.By Country
8.3.South America: Country Analysis
8.3.1.Brazil T-cell Therapy Market Outlook
8.3.1.1.Market Size Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share Forecast
8.3.1.2.1.By Therapy Type
8.3.1.2.2.By Indication
8.3.2.Argentina T-cell Therapy Market Outlook
8.3.2.1.Market Size Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share Forecast
8.3.2.2.1.By Therapy Type
8.3.2.2.2.By Indication
8.3.3.Colombia T-cell Therapy Market Outlook
8.3.3.1.Market Size Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share Forecast
8.3.3.2.1.By Therapy Type
8.3.3.2.2.By Indication
9.Middle East and Africa T-cell Therapy Market Outlook
9.1.Market Size Forecast
9.1.1.By Value
9.2.Market Share Forecast
9.2.1.By Therapy Type
9.2.2.By Indication
9.2.3.By Country
9.3.MEA: Country Analysis
9.3.1.South Africa T-cell Therapy Market Outlook
9.3.1.1.Market Size Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share Forecast
9.3.1.2.1.By Therapy Type
9.3.1.2.2.By Indication
9.3.2.Saudi Arabia T-cell Therapy Market Outlook
9.3.2.1.Market Size Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share Forecast
9.3.2.2.1.By Therapy Type
9.3.2.2.2.By Indication
9.3.3.UAE T-cell Therapy Market Outlook
9.3.3.1.Market Size Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share Forecast
9.3.3.2.1.By Therapy Type
9.3.3.2.2.By Indication
9.3.4.Egypt T-cell Therapy Market Outlook
9.3.4.1.Market Size Forecast
9.3.4.1.1.By Value
9.3.4.2.Market Share Forecast
9.3.4.2.1.By Therapy Type
9.3.4.2.2.By Indication
10.Market Dynamics
10.1.Drivers
10.2.Challenges
11.Market Trends Developments
11.1.Recent Developments
11.2.Product Launches
11.3.Mergers Acquisitions
12.Global T-cell Therapy Market: SWOT Analysis
13.Porter’s Five Forces Analysis
13.1.Competition in the Industry
13.2.Potential of New Entrants
13.3.Power of Suppliers
13.4.Power of Customers
13.5.Threat of Substitute Product
14.Competitive Landscape
14.1.Novartis AG
14.1.1.Business Overview
14.1.2.Company Snapshot
14.1.3.Products Services
14.1.4.Financials (In case of listed)
14.1.5.Recent Developments
14.1.6.SWOT Analysis
14.2.Merck KGaA
14.3.Gilead Sciences Inc.
14.4.TCR2 Therapeutics Inc
14.5.Bluebird Bio Inc.
14.6.Sorrento Therapeutics Inc.
14.7.Fate Therapeutics Inc.
14.8.Pfizer Inc.
14.9.Amgen Inc.
14.10.Celgene Corporation
15.Strategic Recommendations
16.About Us Disclaimer